Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients.

Dekker SEI, Ruhaak LR, Romijn FPHTM, Meijer E, Cobbaert CM, de Fijter JW, Soonawala D; DIPAK Consortium.

Kidney Int Rep. 2019 Mar 22;4(6):833-841. doi: 10.1016/j.ekir.2019.03.011. eCollection 2019 Jun.

2.

Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.

Jonker EFF, Uijlings MAC, Visser LG, Soonawala D.

Vaccine. 2019 May 21;37(23):3133-3139. doi: 10.1016/j.vaccine.2019.04.010. Epub 2019 Apr 24.

PMID:
31029516
3.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH; DIPAK-1 Investigators.

Gastroenterology. 2019 Aug;157(2):481-491.e7. doi: 10.1053/j.gastro.2019.04.018. Epub 2019 Apr 22.

PMID:
31022403
4.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, D'Agnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT; DIPAK-1 Investigators.

JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.

5.

Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in Donation After Circulatory Death Kidney Transplant Recipients.

Bank JR, Ruhaak R, Soonawala D, Mayboroda O, Romijn FP, van Kooten C, Cobbaert CM, de Fijter JW.

Transplantation. 2019 May;103(5):1014-1023. doi: 10.1097/TP.0000000000002472.

PMID:
30300282
6.

Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.

Lantinga MA, de Sévaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH.

Neth J Med. 2018 Jul;76(5):226-234.

7.

Severe Hyponatremia After Drinking Horsetail Juice.

Grim CCA, Meynaar IA, Hammer S, Soonawala D.

Ann Intern Med. 2018 Oct 2;169(7):507-508. doi: 10.7326/L18-0028. Epub 2018 May 29. No abstract available.

PMID:
29809246
8.

Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients.

Kostidis S, Bank JR, Soonawala D, Nevedomskaya E, van Kooten C, Mayboroda OA, de Fijter JW.

Am J Transplant. 2019 Jan;19(1):110-122. doi: 10.1111/ajt.14941. Epub 2018 Jun 15.

PMID:
29786954
9.

Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.

van Dijk EHC, Soonawala D, Rooth V, Hoyng CB, Meijer OC, de Vries APJ, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2443-2449. doi: 10.1007/s00417-017-3823-6. Epub 2017 Oct 23.

10.

The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.

D'Agnolo HMA, Casteleijn NF, Gevers TJG, de Fijter H, van Gastel MDA, Messchendorp AL, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JFM, Zietse R, Gansevoort RT, Drenth JPH.

Am J Nephrol. 2017;46(3):239-248. doi: 10.1159/000479436. Epub 2017 Sep 8.

PMID:
28881341
11.

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.

Lantinga MA, D'Agnolo HM, Casteleijn NF, de Fijter JW, Meijer E, Messchendorp AL, Peters DJ, Salih M, Spithoven EM, Soonawala D, Visser FW, Wetzels JF, Zietse R, Drenth JP, Gansevoort RT; DIPAK Consortium.

Drug Saf. 2017 Feb;40(2):153-167. doi: 10.1007/s40264-016-0486-x.

12.

The rugger-jersey spine.

Appelman-Dijkstra NM, Navas Cañete A, Soonawala D.

Kidney Int. 2016 Aug;90(2):454. doi: 10.1016/j.kint.2016.04.006. No abstract available.

PMID:
27418097
13.

Noninferiority is (too) common in noninferiority trials.

Soonawala D, Dekkers OM, Vandenbroucke JP, Egger M.

J Clin Epidemiol. 2016 Mar;71:118-20. doi: 10.1016/j.jclinepi.2015.11.009. Epub 2015 Dec 1. No abstract available.

PMID:
26607238
14.

A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.

van Dissel JT, Joosten SA, Hoff ST, Soonawala D, Prins C, Hokey DA, O'Dee DM, Graves A, Thierry-Carstensen B, Andreasen LV, Ruhwald M, de Visser AW, Agger EM, Ottenhoff TH, Kromann I, Andersen P.

Vaccine. 2014 Dec 12;32(52):7098-107. doi: 10.1016/j.vaccine.2014.10.036. Epub 2014 Oct 30.

15.

[Transplanting day and night].

Soonawala D.

Ned Tijdschr Geneeskd. 2014;158:A8244. Dutch.

PMID:
25315334
16.

Post-travel screening of asymptomatic long-term travelers to the tropics for intestinal parasites using molecular diagnostics.

Soonawala D, van Lieshout L, den Boer MA, Claas EC, Verweij JJ, Godkewitsch A, Ratering M, Visser LG.

Am J Trop Med Hyg. 2014 May;90(5):835-9. doi: 10.4269/ajtmh.13-0594. Epub 2014 Mar 10.

17.

Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.

Meijer E, Drenth JP, d'Agnolo H, Casteleijn NF, de Fijter JW, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium.

Am J Kidney Dis. 2014 Mar;63(3):446-55. doi: 10.1053/j.ajkd.2013.10.011. Epub 2013 Dec 15.

18.

Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.

Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY.

Vaccine. 2013 Aug 12;31(36):3688-94. doi: 10.1016/j.vaccine.2013.05.104. Epub 2013 Jun 13.

PMID:
23770332
19.

['Non-inferiority' trials. Tips for the critical reader. Research methodology 3].

Soonawala D, Dekkers OM.

Ned Tijdschr Geneeskd. 2012;156(19):A4665. Review. Dutch.

PMID:
22571548
20.

Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease.

Soonawala D, van Eggermond AM, Fidder H, Visser LG.

Inflamm Bowel Dis. 2012 Nov;18(11):2079-85. doi: 10.1002/ibd.22903. Epub 2012 Jan 31.

PMID:
22294313
21.

Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Selman MH, de Jong SE, Soonawala D, Kroon FP, Adegnika AA, Deelder AM, Hokke CH, Yazdanbakhsh M, Wuhrer M.

Mol Cell Proteomics. 2012 Apr;11(4):M111.014563. doi: 10.1074/mcp.M111.014563. Epub 2011 Dec 19.

22.

Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study.

Roukens AH, Soonawala D, Joosten SA, de Visser AW, Jiang X, Dirksen K, de Gruijter M, van Dissel JT, Bredenbeek PJ, Visser LG.

PLoS One. 2011;6(12):e27753. doi: 10.1371/journal.pone.0027753. Epub 2011 Dec 7.

23.

Inconvenience due to travelers' diarrhea: a prospective follow-up study.

Soonawala D, Vlot JA, Visser LG.

BMC Infect Dis. 2011 Nov 20;11:322. doi: 10.1186/1471-2334-11-322.

24.

Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4 in the Netherlands, May 2011.

Kuijper EJ, Soonawala D, Vermont C, van Dissel JT.

Euro Surveill. 2011 Jun 23;16(25). pii: 19897.

25.

Reporting of noninferiority trials was incomplete in trial registries.

Dekkers OM, Soonawala D, Vandenbroucke JP, Egger M.

J Clin Epidemiol. 2011 Sep;64(9):1034-8. doi: 10.1016/j.jclinepi.2010.12.008. Epub 2011 Mar 27.

PMID:
21444195
26.

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.

Soonawala D, Rimmelzwaan GF, Gelinck LB, Visser LG, Kroon FP.

PLoS One. 2011 Jan 31;6(1):e16496. doi: 10.1371/journal.pone.0016496.

27.

Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.

van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P.

Vaccine. 2011 Mar 3;29(11):2100-9. doi: 10.1016/j.vaccine.2010.12.135. Epub 2011 Jan 20.

PMID:
21256189
28.

The immune response to schistosome antigens in formerly infected travelers.

Soonawala D, Geerts JW, de Mos M, Yazdanbakhsh M, Visser LG.

Am J Trop Med Hyg. 2011 Jan;84(1):43-7. doi: 10.4269/ajtmh.2011.10-0260.

29.

Health risks encountered by Dutch medical students during an elective in the tropics and the quality and comprehensiveness of pre-and post-travel care.

Sharafeldin E, Soonawala D, Vandenbroucke JP, Hack E, Visser LG.

BMC Med Educ. 2010 Dec 2;10:89. doi: 10.1186/1472-6920-10-89.

30.

Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.

Soonawala D, Middelburg RA, Egger M, Vandenbroucke JP, Dekkers OM.

Int J Epidemiol. 2010 Dec;39(6):1567-81. doi: 10.1093/ije/dyq136. Epub 2010 Sep 13.

PMID:
20837637
31.

Lipid formulations of amphotericin B and solid organ transplant recipients with central nervous system cryptococcosis.

Soonawala D, Landman GW, Van't Wout JW.

Clin Infect Dis. 2010 Jun 1;50(11):1544; author reply 1544-5. doi: 10.1086/652714. No abstract available.

PMID:
20433357
32.

Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.

Landman GW, Soonawala D.

Clin Infect Dis. 2010 Apr 15;50(8):1200; author reply 1200. doi: 10.1086/651468. No abstract available.

PMID:
20233045
33.

[Diagnostic use of Internet: google the spider].

Soonawala D, Brienen EA, Visser LG.

Ned Tijdschr Geneeskd. 2009;153:A116. Dutch.

PMID:
19785819
34.

Vaccination against travellers' diarrhoea.

Soonawala D, Goorhuis A, Roukens A, Visser L.

Lancet. 2008 Nov 1;372(9649):1542; author reply 1542-3. doi: 10.1016/S0140-6736(08)61647-5. No abstract available.

PMID:
18984180
35.

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG.

Vaccine. 2005 Oct 17;23(43):5120-6.

PMID:
15982790
36.

Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.

Soonawala D, Amin T, Ebmeier KP, Steele JD, Dougall NJ, Best J, Migneco O, Nobili F, Scheidhauer K.

Neuroimage. 2002 Nov;17(3):1193-202.

PMID:
12414259

Supplemental Content

Loading ...
Support Center